Second- and Third-generation Aromatase Inhibitors as First-line Endocrine Therapy in Postmenopausal Metastatic Breast Cancer Patients: A Pooled Analysis of the Randomised Trials

R. M. Elledge

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Number of pages1
JournalBreast Diseases
Issue number1
StatePublished - Apr 1 2007

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this